CASI Pharmaceuticals (CASI) Change in Account Payables (2022 - 2025)
Historic Change in Account Payables for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to $805000.0.
- Pharmaceuticals' Change in Account Payables fell 9989.84% to $805000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $805000.0, marking a year-over-year decrease of 9989.84%. This contributed to the annual value of $2.7 million for FY2024, which is 9993.86% down from last year.
- Pharmaceuticals' Change in Account Payables amounted to $805000.0 in Q2 2025, which was down 9989.84% from $1.2 billion recorded in Q1 2025.
- In the past 5 years, Pharmaceuticals' Change in Account Payables registered a high of $4.4 billion during Q4 2023, and its lowest value of $583000.0 during Q1 2024.
- Its 4-year average for Change in Account Payables is $1.1 billion, with a median of $397.6 million in 2022.
- Per our database at Business Quant, Pharmaceuticals' Change in Account Payables tumbled by 9993.86% in 2024 and then surged by 20487427.1% in 2025.
- Quarter analysis of 4 years shows Pharmaceuticals' Change in Account Payables stood at $3.3 million in 2022, then surged by 134834.63% to $4.4 billion in 2023, then tumbled by 99.94% to $2.7 million in 2024, then crashed by 70.44% to $805000.0 in 2025.
- Its Change in Account Payables stands at $805000.0 for Q2 2025, versus $1.2 billion for Q1 2025 and $2.7 million for Q4 2024.